Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)
September 25, 2024
Since he could remember, Jesus Mata has always had a cough he could not seem to kick. He had no idea that his simple cough was a sign of a serious and life-altering illness.
September 24, 2024
The undergraduate program at Cizik School of Nursing at UTHealth Houston continues to outrank all others in Texas, according to U.S. News & World Report’s 2025 U.S. News Best Colleges publication, which was released on Tuesday.
September 23, 2024
Findings of a study on a novel and minimally invasive laser therapy for patients with drug-resistant epilepsy caused by periventricular nodular heterotopia (PNVH) have been published by UTHealth Houston researchers in American Neurological Association’s Annals of Neurology.
September 20, 2024
On Sept. 1, 2024, four dedicated community leaders joined the UTHealth Houston Development Board. Under the leadership of Maria Pappas, Development Board chair, the board champions the university’s mission to educate health science professionals, conduct innovative research, and model best practices in clinical care and public health. With more than 140 members, the board promotes awareness and philanthropic support for the university’s critical initiatives to advance well-being throughout the region and beyond.
September 19, 2024
Studies by researchers at UTHealth Houston seeking to understand the underlying pathology of Alzheimer’s disease in order to discover new pathways to treatment have earned multiple awards totaling $3.5 million from the Texas Alzheimer’s Research and Care Consortium (TARCC).
September 18, 2024
UTHealth Houston has made an unprecedented commitment to nursing science by establishing the interdisciplinary Cizik Nursing Research Institute. Building on the momentum of Cizik School of Nursing’s growing portfolio of studies funded by the National Institutes of Health, the institute will provide key resources that nurse scientists need to advance meaningful programs of research.
September 16, 2024
Giuseppe N. Colasurdo, MD, announced today that he will be stepping down from his position as president and Alkek-Williams Distinguished Chair at UTHealth Houston. Colasurdo has served in the role for 12 years—the longest tenure of any UTHealth Houston president—and has overseen a period of tremendous growth for the university.
September 16, 2024
When I joined the faculty of what is now our McGovern Medical School in 1995 as an Assistant Professor in Pediatrics, I never imagined the opportunities that awaited me here at UTHealth Houston. At that time, I expected my career to be spent primarily as an educator training future generations of health providers, as a clinician seeing patients in the clinic and hospital, and as an investigator researching treatments for pulmonary disorders. What has unfolded over these past 29 years has been the honor—and the adventure—of a lifetime.
September 16, 2024
UTHealth Houston has enrolled the first patient in the Southeastern United States into a national Phase I/II clinical trial testing whether a neural cell therapy product can help inhibit the abnormal electrical activity that leads to an epileptic seizure.
September 16, 2024
UTHealth Houston and The Ocean Corporation are collaborating on UTHealth Houston’s Space Medicine Training Fellowship program, which now includes a two-week intensive training focused on hyperbaric technologies and analog environments akin to those astronauts experience during extravehicular activities (EVAs), or space walks.
Use the form below to perform a new search.